Walgreens Boots Alliance, Inc. - Common Stock (WBA)
11.34
-0.01 (-0.09%)
NASDAQ · Last Trade: Jun 11th, 6:13 PM EDT
Detailed Quote
Previous Close | 11.35 |
---|---|
Open | 11.37 |
Bid | 11.32 |
Ask | 11.34 |
Day's Range | 11.34 - 11.39 |
52 Week Range | 8.080 - 16.25 |
Volume | 3,718,879 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | 1.000 (8.82%) |
1 Month Average Volume | 10,936,481 |
Chart
About Walgreens Boots Alliance, Inc. - Common Stock (WBA)
Walgreens Boots Alliance is a global healthcare leader that operates a chain of pharmacies, drugstores, and health and wellness retail outlets. The company is known for providing accessible pharmaceutical services and a wide range of health and beauty products. With a commitment to enhancing the health and well-being of its customers, Walgreens Boots Alliance focuses on delivering innovative healthcare solutions, including pharmacy services, immunizations, and health consultations. Additionally, the company engages in retail pharmacy and wholesale distribution, partnering with various healthcare providers to improve patient outcomes and ensure the availability of essential medications and healthcare products. Read More
News & Press Releases
Beverage company Zevia (NYSE:ZVIA) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 2% year on year to $38.02 million. The company expects the full year’s revenue to be around $160.5 million, close to analysts’ estimates. Its non-GAAP loss of $0.04 per share was 59.8% above analysts’ consensus estimates.
Via StockStory · June 11, 2025
LiveRamp (NYSE: RAMP), the leading data collaboration partner, today announced it is powering Walgreens Advertising Group’s (WAG) clean room solution. The partnership enables WAG, the retail media division of Walgreens, to increase access to its first-party data at speed, scale audience insights, and offer more transparency and control to advertisers. This enables brands to enhance media measurement across all platforms in the digital ecosystem and improve ROI with faster time-to-value.
By LiveRamp · Via Business Wire · June 11, 2025
How to upgrade Dad's grooming game for Father's Day
Personal care products for men are booming, both in terms of interest and in sales, now worth over $1 billion nationwide and forecasted to grow to nearly $2 billion by 2028.* To help meet demand, Walgreens is rolling out a " Men's Zone " in nearly 8,000 stores across the country - a dedicated space for this growing category, featuring an assortment of trendy and new men's grooming and skin care products.
Via Brandpoint · June 5, 2025
Preventing Shingles: A Local Pharmacist on the Importance of Getting Vaccinated
(BPT) - When individuals reach age 50, their risk of developing shingles increases, making it more important than ever to understand this painful condition and how to help prevent it.
Via Brandpoint · May 21, 2025
Synergy CHC Corp. (NASDAQ: SNYR), a fast-rising force in the consumer health and wellness space, has appointed Damian Marano as Vice President of Beverage in a strategic move aimed at catapulting the company’s FOCUSfactor Energy Drink into global markets. Marano, a seasoned executive with a decorated history at The Coca-Cola Company (NYSE: KO), brings a wealth of expertise that could unlock powerful international distribution opportunities for the brand.
Via AB Newswire · June 10, 2025
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the consumer retail industry, including Walgreens (NASDAQ:WBA) and its peers.
Via StockStory · June 9, 2025

Synergy CHC Corp. (NASDAQ: SNYR), a provider of consumer health and lifestyle products, most notably “Focusfactor” , today announced a transformative $20 million financing agreement with ACP Agency, LLC , aimed at reducing legacy debt, boosting liquidity, and accelerating the company’s global growth strategy.
Via AB Newswire · June 4, 2025

Amazon Pharmacy introduces caregiver support and expands PillPack access for Medicare users, simplifying medication routines with secure tools and pre-sorted packets.
Via Benzinga · June 3, 2025
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Posts Record Q1 Revenue, Advances AVERSA Fentanyl Development
Nutriband (NASDAQ: NTRB) reported first-quarter revenue of $667,000, a 63% year-over-year increase driven by expanded kinesiology tape production through its Pocono Pharma subsidiary and growing retail presence at Target, Walmart, Walgreens, and CVS. The company continues to prioritize shareholder value by scaling Pocono’s output through penetration pricing strategies while advancing development of AVERSA Fentanyl, an abuse-deterrent transdermal opioid patch. A newly formalized partnership with Kindeva Drug Delivery will support shared development costs in exchange for milestone payments as AVERSA moves toward regulatory approval. The product is projected to reach peak U.S. sales of $80 million to $200 million annually.
Via Investor Brand Network · June 2, 2025

In a sliding market, Walgreens has defied the odds, trading up to $11.26 per share. Its 25.4% gain since December 2024 has outpaced the S&P 500’s 2.4% drop. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Via StockStory · June 2, 2025

Synergy CHC Corp. (NASDAQ: SNYR) is a consumer healthcare and beauty company established in 2010, focuses on marketing and distributing a diverse portfolio of health, wellness, and lifestyle brands across the United States, Canada, and the United Kingdom. The company is anchored by a portfolio of dynamic consumer health and lifestyle brands designed for today's wellness-conscious market:
Via AB Newswire · May 29, 2025

Synergy CHC Corp. (NASDAQ: SNYR), a leading provider of consumer health and lifestyle products, today announced the appointment of Erik Shields as Vice President of Beverage, effective May 26, 2025. The strategic hire comes as the company accelerates its entry into the fast-growing functional beverage market with the expansion of its flagship brain health brand, FOCUSfactor .
Via AB Newswire · May 29, 2025
Synergy CHC Corp. (NASDAQ: SNYR) Powerhouse Brand “FOCUSfactor” Driving Growth
Synergy CHC Corp. (NASDAQ: SNYR) is a consumer healthcare and beauty company established in 2010, focuses on marketing and distributing a diverse portfolio of health, wellness, and lifestyle brands across the United States, Canada, and the United Kingdom. The company is anchored by a portfolio of dynamic consumer health and lifestyle brands designed for today’s wellness-conscious market:
Via AB Newswire · May 28, 2025

If you want to own best-in-class companies, you need to own stocks with a high sticker price.
Via The Motley Fool · May 28, 2025
Running at a loss can be a red flag.
Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.
Via StockStory · May 23, 2025
Walgreens is continuing to invest in innovative pharmacy solutions with the opening of a new micro-fulfillment center (MFC) in Brooklyn Park, Minnesota. This facility will streamline prescription processing and reduce administrative tasks, freeing up pharmacists to focus more on delivering personalized care to their patients. This new facility will support nearly 200 Walgreens stores across the Midwest, including 145 in Minnesota alone, and is expected to process approximately 13 million prescriptions each year. It will also bring more than 175 jobs to the area, as well as significant payroll tax revenue to the state and property tax revenue to the county.
By Walgreens · Via Business Wire · May 20, 2025
ELK GROVE, Calif. - Hanley Investment Group Real Estate Advisors, a nationally recognized real estate brokerage and advisory firm specializing in retail property sales, announced today the $6.1 million sale of a newly constructed single-tenant childcare facility occupied by The Learning Experience in Elk Grove, California, a suburb of Sacramento.
Via AB Newswire · May 20, 2025
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Via StockStory · May 20, 2025
Via The Motley Fool · May 18, 2025
The company said it would announce the next CEO in “due course,” but did not provide a more definite timeline.
Via Stocktwits · May 16, 2025
The U.S. Bankruptcy Court for the District of New Jersey must approve the transactions, and it is currently scheduled to conduct a hearing to approve the sales on May 21, 2025.
Via Stocktwits · May 16, 2025